Reading path

Reading Prevention and Personal Risk

Prevention decisions turn on numbers that are easy to misread: how much a treatment lowers your risk, how many people have to take it for one to benefit, and where your own risk sits to begin with. This path walks you through those numbers in order, so you can read a prevention claim the way a careful clinician reads it and take part in the decision as an equal. By the end you will know why the same result can sound alarming or trivial, and what to ask before starting something meant to keep you well.

The path, step by step

1. 1 Absolute Versus Relative Risk, and the One Question That Cuts Through the Hype

   7 min read

   Every prevention claim starts here, so the reader first learns the single distinction that separates a scary headline from a plain count of people affected.

2. 2 Why '1 in 100' Beats '1 Percent': Communicating Risk Clearly

   4 min read

   Once the reader can tell the two kinds of risk apart, this shows how to translate either one into a natural frequency that the mind actually reads correctly.

3. 3 Number Needed to Treat: How Many People to Help One

   6 min read

   With the numbers made legible, the reader meets the measure that answers the real prevention question: how many people take this for one to benefit.

4. 4 Number Needed to Harm, and How to Read It Against Number Needed to Treat

   6 min read

   Benefit never travels alone, so this pairs the previous step with its mirror image and teaches the reader to weigh the count who are helped against the count who are harmed.

5. 5 Why the Heart Risk Calculator Changed From Pooled Cohort to PREVENT

   5 min read

   Now the reader turns from the treatment to themselves, seeing how a risk model estimates a personal baseline and why the choice of model changes the number.

6. 6 Metabolic Syndrome Explained: A Cluster, Not a Diagnosis

   5 min read

   To ground that baseline in something concrete, this shows how everyday metabolic factors cluster into the risk a prevention model is trying to capture.

7. 7 Risk-Enhancing Factors: The Tiebreakers in a Statin Decision

   4 min read

   Here the reader learns that a single risk score rarely settles a decision, and how added factors nudge a borderline case one way or the other.

8. 8 Why Guidelines Stopped Recommending Aspirin for Most Healthy Adults

   4 min read

   This is the benefit-versus-harm balance playing out in a real prevention story, where accumulating evidence tipped the recommendation for most healthy adults.

9. 9 What the USPSTF Statin Recommendation Says and How It Was Built

   5 min read

   The path closes by showing how a review body folds risk estimates and trial evidence into guidance framed as a shared decision rather than an order.

Each step is a full article on the Reading the Evidence blog.

Back to all reading paths